MARKET

JNJ

JNJ

Johnson&Johnson
NYSE

Real-time Quotes | Nasdaq Last Sale

171.62
+1.64
+0.96%
Opening 12:55 07/23 EDT
OPEN
170.87
PREV CLOSE
169.98
HIGH
171.90
LOW
170.38
VOLUME
2.36M
TURNOVER
--
52 WEEK HIGH
173.65
52 WEEK LOW
133.65
MARKET CAP
451.94B
P/E (TTM)
25.80
1D
5D
1M
3M
1Y
5Y
Analyzing Johnson & Johnson's Unusual Options Activity
On Friday, shares of Johnson & Johnson (NYSE:JNJ) saw unusual options activity. After the option alert, the stock price moved up to $171.59.
Benzinga · 6m ago
Medical chief says 83% of U.S. athletes at the Tokyo Olympics have been vaccinated
marketwatch.com · 38m ago
Stock Market Rally Rebounds To Highs; Snap, Crocs, Chipotle, Netflix Are Key Earnings
The market rally rebounded from Monday's lows, with the S&P 500 hitting a record high. Snap, Crocs and Chipotle were earnings winners.
Investor's Business Daily · 1h ago
This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors
Masking is already being recommended again in parts of California. An infectious disease specialist weighs in.
MarketWatch · 1h ago
Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson (NYSE:JNJ) Investigation
NEW YORK, NY / ACCESSWIRE / July 23, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ('J&J" or 'the Company') (NYSE:JNJ). Investors who purchased J&J shares are encouraged to obtain a...
ACCESSWIRE · 1h ago
U.S. not out of the woods with COVID cases rising in all 50 states, CDC head warns, urges unvaccinated to get their shots
marketwatch.com · 2h ago
'Don’t want to get vaccinated, leave' — hedge fund founder mandates Covid shots in his office
"If somebody wants to fight me over the vaccine mandate, that's fine. Let's take it to the court," SkyBridge's Anthony Scaramucci told CNBC on Friday.
CNBC.com · 3h ago
Johnson & Johnson's VERITAS Vision System available globally
Johnson & Johnson (JNJ) announces the global availability of the VERITAS Vision System, a phacoemulsification (phaco) system, for the treatment of cataracts.The company will offer live demos of the new system in a
Seekingalpha · 4h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson&Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average JNJ stock price target is 187.53 with a high estimate of 203.00 and a low estimate of 160.00.
EPS
Institutional Holdings
Institutions: 3.97K
Institutional Holdings: 1.91B
% Owned: 72.48%
Shares Outstanding: 2.63B
TypeInstitutionsShares
Increased
1.59K
47.03M
New
142
2.50M
Decreased
1.18K
60.14M
Sold Out
72
2.30M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.78%
Pharmaceuticals & Medical Research
+0.65%
Key Executives
Chairman/Chief Executive Officer/Director
Alex Gorsky
Vice Chairman - Management/Chief Scientific Officer
Paulus Stoffels
Vice Chairman - Management
Joaquin Duato
Chief Financial Officer/Executive Vice President
Joseph Wolk
Chief Human Resource Officer/Executive Vice President
Peter Fasolo
Executive Vice President/General Counsel
Michael Ullmann
Executive Vice President
Ashley Mcevoy
Executive Vice President
Thibaut Mongon
Executive Vice President
Michael Sneed
Executive Vice President
Jennifer Taubert
Executive Vice President
Kathryn Wengel
Lead Director/Independent Director
Anne Mulcahy
Independent Director
Mary Beckerle
Independent Director
D. Scott Davis
Independent Director
Ian Davis
Independent Director
Jennifer Doudna
Independent Director
Marillyn Hewson
Independent Director
Hubert Joly
Independent Director
Mark Mcclellan
Independent Director
Charles Prince
Independent Director
A. Eugene Washington
Independent Director
Mark Weinberger
Independent Director
Nadja West
Independent Director
Ronald Williams
Declaration Date
Dividend Per Share
Ex-Div Date
07/19/2021
Dividend USD 1.06
08/23/2021
04/20/2021
Dividend USD 1.06
05/24/2021
01/04/2021
Dividend USD 1.01
02/22/2021
10/22/2020
Dividend USD 1.01
11/23/2020
07/20/2020
Dividend USD 1.01
08/24/2020
04/14/2020
Dividend USD 1.01
05/22/2020
01/02/2020
Dividend USD 0.95
02/24/2020
10/17/2019
Dividend USD 0.95
11/25/2019
07/15/2019
Dividend USD 0.95
08/26/2019
04/25/2019
Dividend USD 0.95
05/24/2019
01/02/2019
Dividend USD 0.9
02/25/2019
10/18/2018
Dividend USD 0.9
11/26/2018
07/16/2018
Dividend USD 0.9
08/27/2018
04/26/2018
Dividend USD 0.9
05/25/2018
01/02/2018
Dividend USD 0.84
02/26/2018
10/19/2017
Dividend USD 0.84
11/27/2017
07/17/2017
Dividend USD 0.84
08/25/2017
04/27/2017
Dividend USD 0.84
05/25/2017
01/03/2017
Dividend USD 0.8
02/24/2017
10/21/2016
Dividend USD 0.8
11/18/2016
About JNJ
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.